BioSpace News Archive

High Throughput Process Development Market Detailed Analysis and Forecast by 2025

In biomanufacturing, high throughout process development tools and technology platforms could be engaged for a simpler and faster development of downstream chromatography processes.

March 24, 2020
·
4 min read
Asthma Copd Drugs Market is Estimated to Register a Promising 4.1% CAGR between 2016 and 2024

The U.S. and China market for asthma and chronic obstructive pulmonary disease drugs is expected to exhibit growth at a steady pace in the next few years.

March 24, 2020
·
4 min read
Digestive Enzymes Market Growth is Expected to Occur at a Healthy CAGR of 13.1% from 2017 to 2025

Presence of a large number of small and large companies makes the global digestive enzymes market competitive in nature.

March 24, 2020
·
4 min read
Drug Development

Novavax Shares Spike After Successful Late-Stage NanoFlu Vaccine Trial

The primary objectives were non-inferior immunogenicity of NanoFlu compared to Sanofi’s Fluzone Quadrivalent based on several 28-day metrics.

March 24, 2020
·
2 min read
·
Mark Terry
Drug Development

Biopharma Industry News for March 24: Update on the Novel Coronavirus

A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.

March 24, 2020
·
4 min read
·
BioSpace Editorial Staff
Business

Roche CEO: Broad Testing for COVID-19 Could Take “Weeks, If Not Months”

“The industry is increasing capacities, but at the same time infection rates are even increasing faster,” said Roche CEO Severin Schwan. “At the moment, capacities are limited. That is why we have to prioritize testing to higher risk patients.”

March 24, 2020
·
4 min read
·
Mark Terry
Business

New York Launches Coronavirus Plasma Trial with Undisclosed Pharma Partner

To combat the growing number of cases, the state is pulling out the stops in testing the use of antibodies from the plasma of recovered COVID-19 patients.

March 24, 2020
·
2 min read
·
Alex Keown
Epigenetics Market – Latest Share and Future Scope Analysis to 2025

The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science.

March 24, 2020
·
4 min read
Anticancer Drugs Market is Expected to Achieve a Valuation of US$155.6 bn by the End of 2025

One of the leading causes of death is cardiovascular diseases followed by cancer.

March 24, 2020
·
4 min read
Heparin Market to Gain a Revenue Worth US$16.3 Billion by 2024

The global heparin market is anticipated to attract growth opportunities on the back of the rising count of surgical procedures and increasing treatment of venous thromboembolism including pulmonary embolism and deep vein thrombosis.

March 24, 2020
·
4 min read